Buscar | Net Pals

adam6324 agregó una foto Other
2026-09-26 06:45:16 - Translate -

Targeted Oncology Biologics Market Valuation to Reach $162.0 Bn by 2036
Rockville, MD., September 26, 2026 — The Targeted Oncology Biologics Market is projected to grow from USD 71.01 billion in 2026 to USD 162.04 billion by 2036, advancing at a 8.6% CAGR during the forecast period, according to Fact.MR. The market is expected to generate an absolute dollar opportunity of USD 91.03 billion between 2026 and 2036. The expansion is closely linked to precision...

0 Commentarios 0 Acciones 7 Views 0 Vista previa

Please log in to like, share and comment!
sarthak1234 agregó una foto Health
2026-07-28 07:06:32 - Translate -

The Evolution of Autoimmune Hemolytic Anemia Treatment: From Immunosuppressive Therapy to Targeted Biologics
Autoimmune hemolytic anemia (AIHA) is a rare and complex red blood cell disorder where the immune system mistakenly produces antibodies that attack and destroy the body's own red blood cells. This leads to varying degrees of anemia, ranging from mild fatigue to life-threatening hemolytic crises. The management of this condition requires careful diagnosis and a tailored therapeutic approach. The...

0 Commentarios 0 Acciones 343 Views 0 Vista previa

Please log in to like, share and comment!
Vanshika04 agregó una foto Health
2026-05-11 11:34:41 - Translate -

Rare Neurological Disease Treatment Market Competitive Landscape and Key Players
The global rare neurological disease treatment market is witnessing substantial growth due to increasing awareness regarding rare neurological disorders, rising investments in orphan drug development, and rapid advancements in biotechnology and precision medicine. Rare neurological diseases are complex disorders that affect the brain, spinal cord, nerves, and muscles, often leading to severe...

0 Commentarios 0 Acciones 1K Views 0 Vista previa

Please log in to like, share and comment!